{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:43:14Z","timestamp":1794246194291,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"French national clinical research grant","award":["PHRC 2010-05"],"award-info":[{"award-number":["PHRC 2010-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0773-y","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T23:38:16Z","timestamp":1518824296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cyclosporine A does not prevent second-eye involvement in Leber\u2019s hereditary optic neuropathy"],"prefix":"10.1186","volume":"13","author":[{"given":"St\u00e9phanie","family":"Leruez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Procaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Amati-Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Prundean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Orssaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Zanlonghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-B\u00e9n\u00e9dicte","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Tilikete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mil\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"773_CR1","doi-asserted-by":"publisher","first-page":"887,896","DOI":"10.1136\/bjo.2009.161539","volume":"95","author":"S Giraudet","year":"2011","unstructured":"Giraudet S, Lamirel C, Amati-Bonneau P, Reynier P, Bonneau D, Mil\u00e9a D, et al. Never too old to harbour a young man\u2019s disease? Br J Ophthalmol. 2011;95:887,896\u20137.","journal-title":"Br J Ophthalmol"},{"key":"773_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/WCO.0b013e3283347b27","volume":"23","author":"D Milea","year":"2010","unstructured":"Milea D, Amati-Bonneau P, Reynier P, Bonneau D. Genetically determined optic neuropathies. Curr Opin Neurol. 2010;23:24\u20138.","journal-title":"Curr Opin Neurol"},{"key":"773_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/eye.2014.37","volume":"28","author":"P Yu-Wai-Man","year":"2014","unstructured":"Yu-Wai-Man P, Votruba M, Moore AT, Chinnery PF. Treatment strategies for inherited optic neuropathies: past, present and future. Eye. 2014;28:521\u201337.","journal-title":"Eye"},{"key":"773_CR4","doi-asserted-by":"crossref","unstructured":"Ohden KL, Tang PH, Lilley CC, Lee MS. Atypical Leber hereditary optic neuropathy: 18 year interval between eyes. J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc. 2016;36:304.","DOI":"10.1097\/WNO.0000000000000346"},{"key":"773_CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1442-9071.2010.02212.x","volume":"38","author":"A Kawasaki","year":"2010","unstructured":"Kawasaki A, Herbst K, Sander B, Milea D. Selective wavelength pupillometry in Leber hereditary optic neuropathy. Clin Exp Ophthalmol. 2010;38:322\u20134.","journal-title":"Clin Exp Ophthalmol"},{"key":"773_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/brain\/118.2.319","volume":"118","author":"P Riordan-Eva","year":"1995","unstructured":"Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber\u2019s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain J Neurol. 1995;118:319\u201337.","journal-title":"Brain J Neurol"},{"key":"773_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrneurol.2012.167","volume":"8","author":"NJ Newman","year":"2012","unstructured":"Newman NJ. Treatment of hereditary optic neuropathies. Nat Rev Neurol. 2012;8:545\u201356.","journal-title":"Nat Rev Neurol"},{"key":"773_CR8","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/brain\/awr170","volume":"134","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Yu-Wai-Man P, Dimitriadis K, Rouleau J, Heck S, Bailie M, et al. A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy. Brain J Neurol. 2011;134:2677\u201386.","journal-title":"Brain J Neurol"},{"key":"773_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","volume":"111","author":"NJ Newman","year":"1991","unstructured":"Newman NJ, Lott MT, Wallace DC. The clinical characteristics of pedigrees of Leber\u2019s hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol. 1991;111:750\u201362.","journal-title":"Am J Ophthalmol"},{"key":"773_CR10","doi-asserted-by":"publisher","first-page":"407.e1","DOI":"10.1016\/j.ajo.2005.03.058","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ, Biousse V, David R, Bhatti MT, Hamilton SR, Farris BK, et al. Prophylaxis for second eye involvement in Leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical Brimonidine Purite. Am J Ophthalmol. 2005;140:407.e1\u2013407.e11.","journal-title":"Am J Ophthalmol"},{"key":"773_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","volume":"123","author":"WJ Feuer","year":"2016","unstructured":"Feuer WJ, Schiffman JC, Davis JL, Porciatti V, Gonzalez P, Koilkonda RD, et al. Gene therapy for Leber hereditary optic neuropathy. Ophthalmology. 2016;123:558\u201370.","journal-title":"Ophthalmology"},{"key":"773_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fneur.2014.00141","volume":"5","author":"C La Morgia","year":"2014","unstructured":"La Morgia C, Carbonelli M, Barboni P, Sadun AA, Carelli V. Medical management of hereditary optic neuropathies. Front Neurol. 2014;5:141.","journal-title":"Front Neurol"},{"key":"773_CR13","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.2174\/0929867033457160","volume":"10","author":"PC Waldmeier","year":"2003","unstructured":"Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ. Cyclophilin D as a drug target. Curr Med Chem. 2003;10:1485\u2013506.","journal-title":"Curr Med Chem"},{"key":"773_CR14","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/j.1742-4658.2006.05213.x","volume":"273","author":"P Bernardi","year":"2006","unstructured":"Bernardi P, Krauskopf A, Basso E, Petronilli V, Blalchy-Dyson E, Di Lisa F, et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006;273:2077\u201399.","journal-title":"FEBS J"},{"key":"773_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/1756-0500-4-557","volume":"4","author":"C Angebault","year":"2011","unstructured":"Angebault C, Gueguen N, Desquiret-Dumas V, Chevrollier A, Guillet V, Verny C, et al. Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration. BMC Res Notes. 2011;4:557.","journal-title":"BMC Res Notes"},{"key":"773_CR16","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.0800962105","volume":"105","author":"L Merlini","year":"2008","unstructured":"Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A, et al. Cyclosporin a corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci. 2008;105:5225\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"773_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/346066","volume":"72","author":"PYW Man","year":"2003","unstructured":"Man PYW, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the north east of England. Am J Hum Genet. 2003;72:333\u20139.","journal-title":"Am J Hum Genet"},{"key":"773_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","volume":"55","author":"JA Fraser","year":"2010","unstructured":"Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55:299\u2013334.","journal-title":"Surv Ophthalmol"},{"key":"773_CR19","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","volume":"18","author":"NJ Newman","year":"2004","unstructured":"Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;18:1144\u201360.","journal-title":"Eye"},{"key":"773_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","volume":"117","author":"P Barboni","year":"2010","unstructured":"Barboni P, Carbonelli M, Savini G, Ramos Cdo VF, Carta A, Berezovsky A, et al. Natural history of Leber\u2019s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117:623\u20137.","journal-title":"Ophthalmology"},{"key":"773_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","volume":"112","author":"G Savini","year":"2005","unstructured":"Savini G, Barboni P, Valentino ML, Montagna P, Cortelli P, De Negri AM, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber\u2019s hereditary optic neuropathy mutations. Ophthalmology. 2005;112:127\u201331.","journal-title":"Ophthalmology"},{"key":"773_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/bjophthalmol-2015-307326","volume":"100","author":"N Balducci","year":"2016","unstructured":"Balducci N, Savini G, Cascavilla ML, La Morgia C, Triolo G, Giglio R, et al. Macular nerve fibre and ganglion cell layer changes in acute Leber\u2019s hereditary optic neuropathy. Br J Ophthalmol. 2016;100:1232\u20137.","journal-title":"Br J Ophthalmol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0773-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:33:25Z","timestamp":1603856005000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0773-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["773"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0773-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,17]]},"assertion":[{"value":"23 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the ethical standards set forth in the Helsinki Declaration (1983). The protocol was approved by the local Ethical Review Committee and by the French Health Products Safety Agency (n\u00b02011\u2013001214-34).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (individual data are entirely unidentifiable).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"33"}}